同步报告病例5（完）：同样的剧本、同样的事故，一个“卢宏斌伤口”变异的同步治疗（尾声）

字号 + –

16 10月 2019

1
2
3
4
5

Author : 伤口世界

原创：十六点五中山二院糖尿病足中心

经过耐心的等待，今天终于等来了毕业照。

在公布毕业照之前，我们再回顾一下从上一期（2019年4月22日）到今天（2019年5月20日）的过程。以下的照片都是患者家属发给我们的，谢谢。

2019年4月27日

足背已经愈合，但为了防止痂下感染，继续应用安尔碘纱布包裹。

2019年5月3日

足底也已经结痂，安尔碘的副作用有增加，要求患者家属不要在足背应用安尔碘纱布包裹

2019年5月10日

足背已经愈合，患者不再发照片，仅仅发足底的照片

2019年5月14日

患者回医院复诊

足背的毕业照

足背完全愈合，足底再继续换药。

2019年5月20日

足底的毕业照

至此，这个糖尿病足病人完全愈合，大约花了5个月，不到5万元，保住了患者的脚。

祝患者继续保护好她的脚，不要再出意外。

736 Views

伤口世界

电子邮件地址该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

Latest from 伤口世界

K2 Content

Diabetes remission in the real world 2024-09-20 00:00

Pam Brown

GP in Swansea

Citation: Brown P (2024) Diabetes Distilled: Diabetes remission in the real world. Diabetes & Primary Care 26: 145–7

Diabetes remission is achievable at scale in the real world, according to early results from the NHS Type 2 Diabetes Path to Remission programme published in Lancet Diabetes & Endocrinology. Of 7540 people referred to the programme between September 2020 and December 2022, a total of 1740 started the total diet replacement section of the programme before January 2022, and 960 (55%) completed the programme. Mean weight loss for the 1710 who started the programme and had follow-up data available was 9.4 kg (8.3%), with a mean weight loss of 10.3 kg (9.3%) among the 945 who completed the programme. Amongst the 945 who completed the programme and had two HbA1c measurements, 32% achieved remission, with mean weight loss of 15.9 kg (14.4%), while overall 27% of those who started the programme achieved remission regardless of whether they completed. Remission rates are lower than in trials such as DiRECT and DIADEM-I, despite similar levels of weight loss. The authors highlight that an additional 17% of participants met the HbA1c targets for remission but continued on metformin and may otherwise have achieved remission. These early results confirm that type 2 diabetes remission is indeed possible at scale in the real world, outside of clinical trials.
Impact of metformin timing on glucose and GLP-1 response 2024-09-19 00:00

Pam Brown GP in Swansea

Citation: Brown P (2024) Diabetes Distilled: Impact of metformin timing on glucose and GLP-1 response. Diabetes & Primary Care 26: 143–4

Glucose-lowering effects in response to normal-release metformin are greater when the drug is given 30 or 60 minutes before, rather than with, food, according to this small study in people with well-controlled type 2 diabetes published in Diabetologia. Endogenous GLP-1 secretion increased when metformin 1000 mg was given 30 or 60 minutes prior to a glucose infusion, whereas there was no increase when the metformin was administered at the same time as the glucose. The results suggest that, if tolerated, administering standard release metformin before meals may lead to improved postprandial glycaemic control.
The importance of getting the correct diabetes diagnosis 2024-09-18 00:00

Jane Diggle Specialist Diabetes Nurse Practitioner, West Yorkshire

Citation: Diggle J (2024) The importance of getting the correct diabetes diagnosis. Diabetes & Primary Care 26: 111–2

Custom Mod Mega1

主任医师、教授、博导，南方医科大学第三附属医院（广东省骨科医院）院长

同步报告病例5（完）：同样的剧本、同样的事故，一个“卢宏斌伤口”变异的同步治疗（尾声）

伤口世界

Latest from 伤口世界

学术会议

伤口世界提示

Custom Mod Mega1

主任医师、教授、博导，南方医科大学第三附属医院（广东省骨科医院）院长

同步报告病例5（完）：同样的剧本、同样的事故，一个“卢宏斌伤口”变异的同步治疗（尾声）

伤口世界

Latest from 伤口世界

消息订阅

学术会议

伤口世界提示